Skip to main content
. 2016 Feb 28;68(5):663–670. doi: 10.1016/j.ihj.2015.12.011

Table 4.

Antiarrhythmic use on the day of the visit.

Atrial fibrillation treatment n (%) (n = 301)
Patients with at least one AAD 249 (82.7)
Class IC (Flecainide, other) 4 (1.3)
Class II, beta-blockers 116 (38.5)
Class III 118 (39.2)
Amiodarone 112 (37.2)
Sotalol 6 (2.0)
Others 4 (1.3)
Class IV, calcium-channel blockers 75 (24.9)
Cardiac glycosides 96 (31.9)

AAD, antiarrhythmic drug.